Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Memory and Roche to initiate biomarker clinical study of MEM-3454 for schizophrenia

Feb. 20, 2008

Cognitive improvement seen with intranasal insulin in early Alzheimer's disease

Feb. 20, 2008

Newron completes enrollment in phase II study of ralfinamide in post-op dental pain

Feb. 19, 2008

Lundbeck initiates enrollment in phase II clinical study of Lu-AA-34893 for bipolar disorder

Feb. 19, 2008

LAT-967 shows potential for AD by inducing Sp1 degradation

Feb. 19, 2008

FDA grants fast track status to levodopa/carbidopa intestinal gel

Feb. 19, 2008

Icagen announces completion of investment by Pfizer

Feb. 19, 2008

FDA grants approval to Diamyd to initiate phase I trial of NP-2 for chronic pain

Feb. 19, 2008

Canada approves Wellbutrin XL for prevention of seasonal major depressive illness

Feb. 18, 2008

Neuroprotective effects of lithium in preclinical and clinical studies of ALS

Feb. 18, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026